HALO

#910
Halozyme Therapeutics, Inc. - Common Stock
66.5 4 USD
-2.41%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
66.54
66.54
Rango anual
0.68
82.22
Cambio diario
-2.41%
Variación mensual
+5.27%
Variación en los últimos 6 meses
-7.07%
Cambio anual
-0.39%
Cierres anteriores
68.1 8
Open
66.5 4
Mínimo
66.5 4
High
66.5 4
Volumen
249
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

Noticias